IDEXo — Idex Biometrics ASA Cashflow Statement
0.000.00%
TechnologyHighly SpeculativeMicro Cap
- NOK57.98m
- NOK72.01m
- $4.14m
Annual cashflow statement for Idex Biometrics ASA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -32.3 | -26.9 | -32.5 | -32.7 | -26.6 |
Depreciation | |||||
Non-Cash Items | 2.07 | 2.32 | 3.2 | 2.35 | 1.33 |
Other Non-Cash Items | |||||
Changes in Working Capital | 1.4 | -0.478 | -0.07 | -2.37 | -3.33 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -27.2 | -23.3 | -27.5 | -31.4 | -27 |
Capital Expenditures | -0.85 | -0.333 | -0.141 | -0.267 | -0.243 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.129 | 0.101 | -0.002 | 0.107 | 0.247 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.721 | -0.232 | -0.143 | -0.16 | 0.004 |
Financing Cash Flow Items | -0.5 | -0.5 | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 33 | 17.4 | 54.1 | 14 | 22.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 4.49 | -6.83 | 26.5 | -17.6 | -4.77 |